IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 48 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus

Chakraborti C K

Year : 2008| Volume: 40| Issue : 1 | Page no: 10-14

   This article has been cited by
1 Investigating Commercial Incentives for Innovation: An Application in Traditional Medicine
Debdatta Saha, T. M. Vasuprada
Studies in Microeconomics. 2021; 9(1): 66
[Pubmed]  [Google Scholar] [DOI]
2 Pitfalls and promises of raw drug identification techniques in the ayurvedic industry: an overview
Remya Unnikrishnan, Suma Arun Dev, R. Jayaraj
3 Biotech. 2020; 10(11)
[Pubmed]  [Google Scholar] [DOI]
3 Dipeptidyl peptidase 8 and 9 - Guilty by association?
Pitman, M.R., Sulda, M.L., Kuss, B., Abbott, C.A.
Frontiers in Bioscience. 2009; 14(10): 3619-3633
[Pubmed]  [Google Scholar]
4 Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of type 2 diabetes
Gupta, R., Walunj, S.S., Tokala, R.K., Parsa, K.V.L., Singh, S.K., Pal, M.
Current Drug Targets. 2009; 10(1): 71-87
[Pubmed]  [Google Scholar]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow